NCT00413452View on ClinicalTrials.gov

Etanercept SFP in RA Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

224

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

August 31, 2007

Study Completion Date

October 31, 2007

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Etanercept

50 mg once weekly

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
collaborator

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

lead

Amgen

INDUSTRY

NCT00413452 - Etanercept SFP in RA Patients | Biotech Hunter | Biotech Hunter